Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$375,195
+$55,920 QoQ
Shares Held
1,491
+1.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#3,421
of 4,153 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Laraway Financial Advisors Inc holds $5,704,791 across 7 Drug Manufacturers - General names. ABBV ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,359 | $2,829,455 | |
| 2 | JNJ |
Johnson & Johnson
|
4,770 | $1,211,436 | |
| 3 | NVS |
Novartis AG
|
2,467 | $386,628 | |
| 4 | NVO |
Novo Nordisk A S
|
7,906 | $379,013 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
1,491 | $375,195 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,729 | $350,676 | |
| 7 | PFE |
Pfizer Inc
|
7,159 | $172,388 |
All Filings in ABBV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $375,195 | 1,491 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $319,275 | 1,468 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $403,741 | 1,767 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $410,288 | 1,772 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $328,918 | 1,772 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $376,297 | 1,796 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $318,971 | 1,795 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $354,476 | 1,795 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $307,878 | 1,795 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $326,687 | 1,794 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $278,016 | 1,794 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $267,264 | 1,793 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $244,939 | 1,818 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $289,575 | 1,817 | Shares | Sole | 2023-06-09 | |
| 2022-12-31 | $293,645 | 1,817 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $248,288 | 1,850 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $283,346 | 1,850 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $308,009 | 1,900 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $250,490 | 1,850 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||